ArticleAnnals of pediatric cardiology
Cardiopulmonary exercise testing-derived circulatory power predicts major adverse cardiac events in adults with repaired tetralogy of Fallot.
Article in Annals of pediatric cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adults with repaired tetralogy of Fallot (rTOF) remain at increased risk for major adverse cardiac events (MACEs). Cardiopulmonary exercise testing (CPET) is increasingly used for risk stratification, though prognostic data beyond peak oxygen consumption (VO Methods: Clinical and CPET data from 47 adults with rTOF who underwent symptom-limited CPET were retrospectively analyzed. MACE was defined as cardiac-related hospitalization, device implantation, surgical intervention, or death. Associations between CPET variables and MACE were assessed using multivariable Cox regression adjusted for age, sex, and body mass index. Discriminative performance was evaluated using receiver operating characteristic (ROC) analysis. Results: Over a mean follow-up of 20.8 months, 9 patients (19.1%) experienced MACE. Peak VO Conclusions: Peak VO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.